Banca Mediolanum S.p.A.

WBAG:BMED Stock Report

Market Cap: €8.2b

Banca Mediolanum Future Growth

Future criteria checks 2/6

Banca Mediolanum's earnings are forecast to decline at 3.9% per annum while its annual revenue is expected to grow at 13.8% per year. EPS is expected to decline by 2.5% per annum. Return on equity is forecast to be 20.6% in 3 years.

Key information

-3.9%

Earnings growth rate

-2.5%

EPS growth rate

Diversified Financial earnings growth-14.9%
Revenue growth rate13.8%
Future return on equity20.6%
Analyst coverage

Good

Last updated18 Nov 2024

Recent future growth updates

No updates

Recent updates

Earnings and Revenue Growth Forecasts

WBAG:BMED - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
12/31/20263,162876835N/A2
12/31/20253,094881848N/A3
12/31/20243,064999872N/A2
9/30/20242,091924N/AN/AN/A
6/30/20242,066908581631N/A
3/31/20241,984864N/AN/AN/A
12/31/20231,870822-1,806-1,754N/A
9/30/20231,712702N/AN/AN/A
6/30/20231,587629132200N/A
3/31/20231,468571N/AN/AN/A
12/31/20221,3775072,2392,298N/A
9/30/20221,585714N/AN/AN/A
6/30/20221,5476851,0341,093N/A
3/31/20221,585694N/AN/AN/A
12/31/20211,599713848909N/A
9/30/20211,425560N/AN/AN/A
6/30/20211,40855381119N/A
3/31/20211,310496N/AN/AN/A
12/31/20201,215434-1824N/A
9/30/20201,457531N/AN/AN/A
6/30/20201,445545162192N/A
3/31/20201,470566N/AN/AN/A
12/31/20191,469565328363N/A
9/30/20191,038268N/AN/AN/A
6/30/20191,012252257305N/A
3/31/20191,005268N/AN/AN/A
12/31/2018987256312357N/A
9/30/20181,031373181248N/A
6/30/20181,006359N/A278N/A
3/31/2018944355N/AN/AN/A
12/31/2017970380N/A275N/A
9/30/2017938368N/AN/AN/A
6/30/2017983420N/A-789N/A
3/31/20171,007405N/AN/AN/A
12/31/2016985394N/A-849N/A
9/30/20161,068432N/AN/AN/A
6/30/20161,014382N/A155N/A
3/31/20161,009374N/AN/AN/A
12/31/20151,103439N/A-7,651N/A
12/31/2013868188N/A-454N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: BMED's earnings are forecast to decline over the next 3 years (-3.9% per year).

Earnings vs Market: BMED's earnings are forecast to decline over the next 3 years (-3.9% per year).

High Growth Earnings: BMED's earnings are forecast to decline over the next 3 years.

Revenue vs Market: BMED's revenue (13.8% per year) is forecast to grow faster than the Austrian market (0.8% per year).

High Growth Revenue: BMED's revenue (13.8% per year) is forecast to grow slower than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: BMED's Return on Equity is forecast to be high in 3 years time (20.6%)

Discover growth companies

7D

1Y

7D

1Y

7D

1Y